Patents by Inventor Kerstin LAIB SAMPAIO

Kerstin LAIB SAMPAIO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCMV entry inhibitors
    Patent number: 11390661
    Abstract: Subject matter of the present invention is a soluble PDGFR-alpha-Fc chimera or a PDGFR-alpha derived peptide or an anti-PDGFR-alpha antibody or a PDGFR-alpha antibody fragment or anti-PDGFR-alpha non-Ig scaffold for inhibiting HCMV entry for use in a method of treatment in a subject that has been infected by HCMV or for use in a method of prophylaxis of HCMV infection in a subject that has not yet been infected by HCMV.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: July 19, 2022
    Assignee: AiCuris Anti-Infective Cures GmbH
    Inventors: Christian Sinzger, Cora Stegmann, Kerstin Laib Sampaio, Barbara Adler
  • HCMV ENTRY INHIBITORS
    Publication number: 20210380664
    Abstract: Subject matter of the present invention is a soluble PDGFR-alpha-Fc chimera or a PDGFR-alpha derived peptide or an anti-PDGFR-alpha antibody or a PDGFR-alpha antibody fragment or anti-PDGFR-alpha non-Ig scaffold for inhibiting HCMV entry for use in a method of treatment in a subject that has been infected by HCMV or for use in a method of prophylaxis of HCMV infection in a subject that has not yet been infected by HCMV.
    Type: Application
    Filed: August 6, 2021
    Publication date: December 9, 2021
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Christian SINZGER, Cora STEGMANN, Kerstin LAIB SAMPAIO, Barbara ADLER
  • HCMV ENTRY INHIBITORS
    Publication number: 20190161532
    Abstract: Subject matter of the present invention is a soluble PDGFR-alpha-Fc chimera or a PDGFR-alpha derived peptide or an anti-PDGFR-alpha antibody or a PDGFR-alpha antibody fragment or anti-PDGFR-alpha non-Ig scaffold for inhibiting HCMV entry for use in a method of treatment in a subject that has been infected by HCMV or for use in a method of prophylaxis of HCMV infection in a subject that has not yet been infected by HCMV.
    Type: Application
    Filed: June 27, 2017
    Publication date: May 30, 2019
    Applicant: AiCuris Anti-Infective Cures GmbH
    Inventors: Christian SINZGER, Cora STEGMANN, Kerstin LAIB SAMPAIO, Barbara ADLER